The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Join Foundation President and Chief Executive Officer, Michael Boyle, MD and other Foundation staff as they highlight the latest developments in our drug pipeline, discuss how our care model is evolving to meet changing needs, and provide an update on the Foundation’s Path to a Cure – the ambitious research agenda focused on developing treatments for all people with CF and ultimately, a cure. Also, hear the latest on the Infection Research Initiative, including the latest studies aimed at tackling infections.
Moderator(s):
Michael
Boyle,
MD,
President and CEO,
Cystic Fibrosis Foundation
Panelist(s):
Ann
Field,
PhD,
Senior Director, Drug Discovery and Development
William
Skach,
MD,
Executive Vice President and Chief Scientific Officer
JP
Clancy,
MD,
Senior Vice President of Clinical Research,
Cystic Fibrosis Foundation
Credits
Credits: None available.
You must be logged in and own this session in order to
post comments.
